WHO ICTRP trial
Study examining the PROMUS Element everolimus-eluting stent in multi-center…
JPRN-UMIN000021122 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000021122 |
|---|---|
| Public title | Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion Subsets (OCT and IVUS sub analysis) |
| Scientific title | Study examining the PROMUS Element everolimus-eluting stent in multi-center Coronary Intervention of complex Arterial Lesion Subsets (OCT and IVUS sub analysis) - SPECIALIST registry |
| Primary sponsor | The PCI Guideline Research Society |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Complex coronary artery disease |
| Interventions | Platinum chromium everolimus-eluting stent (PtCr-EES) (manufactured as PROMUS Element by Boston Scientific) |
| Registration date | Feb 21, 2016 |
| Target size | 50 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: